A novel ex vivo tracheobronchomalacia model for airway stent testing and in vivo model refinement
Objectives We sought to develop an ex vivo trachea model capable of producing mild,
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …
A Novel Ex Vivo Tracheobronchomalacia Model for Airway Stent Testing and In Vivo Model Refinement.
A Mondal, GA Visner, AK Kaza… - The Journal of Thoracic …, 2023 - europepmc.org
Objectives We sought to develop an ex vivo trachea model capable of producing mild,
moderate and severe tracheobronchomalacia (TBM) for optimizing airway stent design. We …
moderate and severe tracheobronchomalacia (TBM) for optimizing airway stent design. We …
A novel ex vivo tracheobronchomalacia model for airway stent testing and in vivo model refinement
A Mondal, GA Visner, AK Kaza… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Objectives We sought to develop an ex vivo trachea model capable of producing mild,
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …
A novel ex vivo tracheobronchomalacia model for airway stent testing and in vivo model refinement
A Mondal, GA Visner, AK Kaza, PE Dupont - The Journal of Thoracic and …, 2023 - jtcvs.org
Objectives We sought to develop an ex vivo trachea model capable of producing mild,
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …
A novel ex vivo tracheobronchomalacia model for airway stent testing and in vivo model refinement
A Mondal, GA Visner, AK Kaza, PE Dupont - The Journal of Thoracic and …, 2023 - jtcvs.org
Objectives We sought to develop an ex vivo trachea model capable of producing mild,
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …
moderate, and severe tracheobronchomalacia for optimizing airway stent design. We also …